Xiaoying Wang
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Hepatology 16
- Hepatocellular Carcinoma Treatment and Prognosis 16
- Oncology 28
- Cancer Immunotherapy and Biomarkers 7
Xiaoying Wang
85 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hepatology 638
- Immunology 1.5k
- Oncology 1.7k
- Cancer Research 890
- Molecular Biology 1.6k
Countries citing papers authored by Xiaoying Wang
This map shows the geographic impact of Xiaoying Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Wang more than expected).
Fields of papers citing papers by Xiaoying Wang
This network shows the impact of papers produced by Xiaoying Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Wang. The network helps show where Xiaoying Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoying Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 6 | |
| 6 | Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma Hit paper breakdown → | 2023 | 354 |
| 7 | 2023 | 21 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 0 | |
| 10 | 2021 | 144 | |
| 11 | 2021 | 69 | |
| 12 | 2020 | 18 | |
| 13 | 2019 | 114 | |
| 14 | 2019 | 2 | |
| 15 | 2013 | 182 | |
| 16 | [Significance of magnetic resonance imaging in the detection of iron overload]. | 2013 | 1 |
| 17 | 2012 | 136 | |
| 18 | 2011 | 155 | |
| 19 | 2010 | 81 | |
| 20 | 2008 | 236 |
About Xiaoying Wang
Xiaoying Wang is a scholar working on Hepatology, Oncology, Cancer Research, Immunology and Surgery, having authored 88 papers that have together received 4.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers), Immune cells in cancer (11 papers), Immunotherapy and Immune Responses (8 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Hepatology (638 citations), Immunology (1.5k citations), Oncology (1.7k citations), Cancer Research (890 citations) and Molecular Biology (1.6k citations). Xiaoying Wang has collaborated with scholars based in China, Ethiopia and India. Frequent co-authors include Jia Fan, Qiang Gao, Jian Zhou, Shuang‐Jian Qiu, Yong‐Sheng Xiao, Zhen‐Bin Ding, Zhao–You Tang, Yang Xu, Yiwei Li and Ying‐Hong Shi. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology, Clinical Cancer Research, Annals of Surgical Oncology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.